SHP-1-Pyk2-Src protein complex and p38 MAPK pathways independently regulate IL-10 production in lipopolysaccharide-stimulated macrophages

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2589-2603

  Okenwa, Chinonso ^a   Kumar, Ashok ^a,b   Rego, Dorothy ^a   Konarski, Yulia ^a   Nilchi, Ladan ^a   Wright, Kathryn ^a   Kozlowski, Maya ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHP 1 GENE; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOCAL ADHESION KINASE 2; IMMUNOPRECIPITATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84883389372     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300466     Document Type: Article

References (69)

1. Netea, M. G., C. van der Graaf, J. W. Van der Meer, and B. J. Kullberg. 2004. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75: 749-755.
2. Kollias, G., E. Douni, G. Kassiotis, and D. Kontoyiannis. 1999. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169: 175-194.
3. Neta, R., T. J. Sayers, and J. J. Oppenheim. 1992. Relationship of TNF to interleukins. Immunol. Ser. 56: 499-566.
4. Sabat, R., G. Grütz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk, and J. Geginat. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev. 21: 331-344.
5. Scumpia, P. O., and L. L. Moldawer. 2005. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit. Care Med. 33(12, Suppl)S468-S471.
6. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
7. Ouyang, W., S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29: 71-109.
8. + TH1-like responses. J. Clin. Invest. 98: 1010-1020.
9. Szatmáry, Z. 1999. Tumor necrosis factor-α: molecular-biological aspects minireview. Neoplasma 46: 257-266.
10. Kim, M. H., D. S. Yoo, S. Y. Lee, S. E. Byeon, Y. G. Lee, T. Min, H. S. Rho, M. H. Rhee, J. Lee, and J. Y. Cho. 2011. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broadspectrum anti-inflammatory effects. Pharmazie 66: 293-300.
11. Guma, M., D. Stepniak, H. Shaked, M. E. Spehlmann, S. Shenouda, H. Cheroutre, I. Vicente-Suarez, L. Eckmann, M. F. Kagnoff, and M. Karin. 2011. Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J. Exp. Med. 208: 1889-1900.
12. Brightbill, H. D., S. E. Plevy, R. L. Modlin, and S. T. Smale. 2000. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164: 1940-1951.
13. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276: 13664-13674.
14. Tsygankov, A. Y. 2003. Non-receptor protein tyrosine kinases. Front. Biosci. 8: s595-s635.
15. Hubbard, S. R., and J. H. Till. 2000. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69: 373-398.
16. Hubbard, S. R. 2002. Protein tyrosine kinases: autoregulation and smallmolecule inhibition. Curr. Opin. Struct. Biol. 12: 735-741.
17. Fukami, Y., T. Nagao, T. Iwasaki, and K. Sato. 2002. Inhibition and activation of c-Src: the head and tail of a coin. Pharmacol. Ther. 93: 263-270.
18. Kefalas, P., T. R. Brown, and P. M. Brickell. 1995. Signalling by the p60c-src family of protein-tyrosine kinases. Int. J. Biochem. Cell Biol. 27: 551-563.
19. English, B. K., S. L. Orlicek, Z. Mei, and E. A. Meals. 1997. Bacterial LPS and IFN-γ trigger the tyrosine phosphorylation of vav in macrophages: evidence for involvement of the hck tyrosine kinase. J. Leukoc. Biol. 62: 859-864.
20. Ziegler, S. F., C. B. Wilson, and R. M. Perlmutter. 1988. Augmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation. J. Exp. Med. 168: 1801-1810.
21. Stefanová, I., M. L. Corcoran, E. M. Horak, L. M. Wahl, J. B. Bolen, and I. D. Horak. 1993. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J. Biol. Chem. 268: 20725-20728.
22. Anand, A. R., M. Cucchiarini, E. F. Terwilliger, and R. K. Ganju. 2008. The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells. J. Immunol. 180: 5636-5644.
23. Williams, L. M., and A. J. Ridley. 2000. Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of Pyk2 and paxillin in monocytes and macrophages. J. Immunol. 164: 2028-2036.
24. Avraham, H., S. Y. Park, K. Schinkmann, and S. Avraham. 2000. RAFTK/Pyk2-mediated cellular signalling. Cell. Signal. 12: 123-133.
25. Kelly, E. K., L.Wang, and L. B. Ivashkiv. 2010. Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages. J. Immunol. 184: 5545-5552.
26. Wang, L., I. Tassiulas, K. H. Park-Min, A. C. Reid, H. Gil-Henn, J. Schlessinger, R. Baron, J. J. Zhang, and L. B. Ivashkiv. 2008. "Tuning" of type I interferoninduced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat. Immunol. 9: 186-193.
27. Neel, B. G., and N. K. Tonks. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9: 193-204.
28. Hunter, T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
29. Roskoski, R., Jr. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331: 1-14.
30. Tsui, F. W., A. Martin, J. Wang, and H. W. Tsui. 2006. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol. Res. 35: 127-136.
31. Chong, Z. Z., and K. Maiese. 2007. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol. Histopathol. 22: 1251-1267.
32. Zhang, J., A. K. Somani, and K. A. Siminovitch. 2000. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12: 361-378.
33. Kon-Kozlowski, M., G. Pani, T. Pawson, and K. A. Siminovitch. 1996. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J. Biol. Chem. 271: 3856-3862.
34. Pani, G., M. Kozlowski, J. C. Cambier, G. B. Mills, and K. A. Siminovitch. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptorassociated protein involved in the regulation of B cell signaling. J. Exp. Med. 181: 2077-2084.
35. Chan, A. C., D. M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12: 555-592.
36. Yeung, Y. G., Y. Wang, D. B. Einstein, P. S. Lee, and E. R. Stanley. 1998. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. J. Biol. Chem. 273: 17128-17137.
37. Klingmüller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80: 729-738.
38. Massa, P. T., and C. Wu. 1996. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-γ signaling in neural cells. J. Immunol. 157: 5139-5144.
39. Kozlowski, M., L. Larose, F. Lee, D. M. Le, R. Rottapel, and K. A. Siminovitch. 1998. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol. Cell. Biol. 18: 2089-2099.
40. Taylor, A., M. Akdis, A. Joss, T. Akkoç, R. Wenig, M. Colonna, I. Daigle, E. Flory, K. Blaser, and C. A. Akdis. 2007. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J. Allergy Clin. Immunol. 120: 76-83.
41. Rego, D., A. Kumar, L. Nilchi, K. Wright, S. Huang, and M. Kozlowski. 2011. IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein b and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages. J. Immunol. 186: 5443-5456.
42. Hardin, A. O., E. A. Meals, T. Yi, K. M. Knapp, and B. K. English. 2006. SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages. Biochem. Biophys. Res. Commun. 342: 547-555.
43. Khaled, A. R., E. J. Butfiloski, E. S. Sobel, and J. Schiffenbauer. 1998. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NFkB. Cell. Immunol. 185: 49-58.
44. Zhao, J., D. M. Brooks, and D. I. Lurie. 2006. Lipopolysaccharide- activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-α, and IL-1β. Glia 53: 304-312.
45. Shultz, L. D. 1987. Pleiotropic mutations causing abnormalities in the murine immune system and the skin. Curr. Probl. Dermatol. 17: 236-250.
46. Shultz, L. D., T. V. Rajan, and D. L. Greiner. 1997. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15: 302-307.
47. Giles, R. V. 2000. Antisense oligonucleotide technology: from EST to therapeutics. Curr. Opin. Mol. Ther. 2: 238-252.
48. Walev, I., S. C. Bhakdi, F. Hofmann, N. Djonder, A. Valeva, K. Aktories, and S. Bhakdi. 2001. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc. Natl. Acad. Sci. USA 98: 3185-3190.
49. Banville, D., R. Stocco, and S. H. Shen. 1995. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 27: 165-173.
50. Amin, S., A. Kumar, L. Nilchi, K. Wright, and M. Kozlowski. 2011. Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through cjun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors. Mol. Cancer Res. 9: 1112-1125.
51. Graziani-Bowering, G., L. G. Filion, P. Thibault, and M. Kozlowski. 2002. CD4 is active as a signaling molecule on the human monocytic cell line Thp-1. Exp. Cell Res. 279: 141-152.
52. Ocuin, L. M., Z. M. Bamboat, V. P. Balachandran, M. J. Cavnar, H. Obaid, G. Plitas, and R. P. DeMatteo. 2011. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J. Leukoc. Biol. 89: 423-432.
53. Ishida, H., R. Hastings, J. Kearney, and M. Howard. 1992. Continuous antiinterleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175: 1213-1220.
54. Ishida, H., R. Hastings, L. Thompson-Snipes, and M. Howard. 1993. Modified immunological status of anti-IL-10 treated mice. Cell. Immunol. 148: 371-384.
55. Dhingra, S., A. K. Bagchi, A. L. Ludke, A. K. Sharma, and P. K. Singal. 2011. Akt regulates IL-10 mediated suppression of TNFα-induced cardiomyocyte apoptosis by upregulating Stat3 phosphorylation. PLoS ONE 6: e25009.
56. Daftarian, P. M., A. Kumar, M. Kryworuchko, and F. Diaz-Mitoma. 1996. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α. J. Immunol. 157: 12-20.
57. Kim, K. H., D. I. Kim, S. H. Kim, E. M. Jung, J. H. Kang, E. B. Jeung, and M. P. Yang. 2011. Trans-10, cis-12-conjugated linoleic acid attenuates tumor necrosis factor-α production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells through induction of interleukin-10. Cytokine 56: 224-230.
58. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176: 5788-5796.
59. Yang, Z., D. M. Mosser, and X. Zhang. 2007. Activation of the MAPK, ERK, following infection of macrophages. J. Immunol. 178: 1077-1085.
60. Lucas, M., X. Zhang, and V. Prasanna, and Leishmania amazonensis D. M. Mosser. 2005. ERK activation following macrophage FcγR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 175: 469-477.
61. Saraiva, M., J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and A. O'Garra. 2009. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31: 209-219.
62. 133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J. Biol. Chem. 281: 31647-31658.
63. Somani, A. K., J. S. Bignon, G. B. Mills, K. A. Siminovitch, and D. R. Branch. 1997. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 272: 21113-21119.
64. Chiang, G. G., and B. M. Sefton. 2001. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 276: 23173-23178.
65. Boulet, I., S. Ralph, E. Stanley, P. Lock, A. R. Dunn, S. P. Green, and W. A. Phillips. 1992. Lipopolysaccharide- and interferon-γ-induced expression of hck and lyn tyrosine kinases in murine bone marrow-derived macrophages. Oncogene 7: 703-710.
66. Roskoski, R., Jr. 2004. Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324: 1155-1164.
67. Dikic, I., G. Tokiwa, S. Lev, S. A. Courtneidge, and J. Schlessinger. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550.
68. English, B. K., J. N. Ihle, A. Myracle, and T. Yi. 1993. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J. Exp. Med. 178: 1017-1022.
69. Doyle, S. L., C. A. Jefferies, and L. A. O'Neill. 2005. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFκB activation by lipopolysaccharide. J. Biol. Chem. 280: 23496-23501.